Le Lézard
Classified in: Health
Subject: PSF

The Canadian Cancer Society is calling for a united show of support for those affected by cancer and to help hope bloom this April


Nearly half of people in Canada are expected to be diagnosed with cancer in their lifetime. April's Daffodil Month unites people to fund world-leading cancer research and support programs that are saving and improving lives. 

TORONTO, April 2, 2024 /CNW/ - Daffodil Month is the Canadian Cancer Society's (CCS) signature fundraising initiative held annually in April during Cancer Awareness Month and inspires people to rally together to improve the cancer experience and help people with cancer live longer, fuller lives. Donations fund world-leading, innovative cancer research, critical support programs and advocacy with governments to bring about healthy public policies that benefit the health of all people in Canada.

For people living with cancer, the daffodil is a symbol of hope. A Canadian tradition for more than 65 years, the Canadian Cancer Society's Daffodil Month has a rich legacy of changing the future of cancer. According to CCS, the survival rate in Canada (for all cancers combined) is now around 63% compared to the 1940s when the survival rate was barely 25%. For some types of cancer, the survival rate is now 90% or higher. This considerable increase can be largely attributed to advancements in the most promising research across the entire cancer continuum (prevention, diagnosis, treatment and living with and beyond cancer) with funding from Daffodil Month significantly contributing to this progress; but more support is needed while cancer continues to be the leading cause of death in Canada.

"We know that to take on something as big as cancer, it takes all of us. Progress is possible when we act together," says Andrea Seale, Chief Executive Officer of the Canadian Cancer Society. "Daffodil Month has an important purpose - to raise funds, to remember the people we love who we have lost to cancer and show our support to people who are going through it right now. It's a reminder that things can get better. We are making progress every day."

In Canada, there are currently 1.5 million people living with or beyond the disease. Cancer will impact us all, in one way or another. Donating to the Canadian Cancer Society this April during Daffodil Month is a powerful way for people to transform the future of cancer forever by funding the brightest minds in cancer research and providing a compassionate support system that makes a real difference in people's lives.

This Daffodil Month, CCS is inviting people across Canada to join us to help hope bloom for those affected by cancer by visiting cancer.ca/daffodil to:

About the Canadian Cancer Society

The Canadian Cancer Society works tirelessly to save and improve lives. We raise funds to fuel the brightest minds in cancer research. We provide a compassionate support system for all those affected by cancer, across Canada and for all types of cancer. Together with patients, supporters, donors and volunteers, we work to create a healthier future for everyone. Because to take on cancer, it takes all of us. It takes a society.

Help us make a difference. Call 1-888-939-3333 or visit cancer.ca today. 

SOURCE Canadian Cancer Society (National Office)


These press releases may also interest you

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business...

at 01:05
Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in Australia, Singapore, Switzerland, and...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% in USD)Biosimilar business growing 21%...

at 01:00
dsm-firmenich today announces that, as part of its share repurchase program to cover share plans as announced on April 8, 2024, during the period from April 29, 2024 up to and including May 3, 2024 a total number of 547,165 shares have been...

at 00:45
Q1 2024 Results Further strong market share gains, disciplined execution Revenues flat yoy, outperforming markets; Adecco's relative revenue growth +600 bpsBy GBU, Adecco, +1% yoy, of which APAC +14%, Southern Europe & EEMENA +8%, DACH +7%; LHH -5%,...



News published on and distributed by: